Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Follow us
Alexa global traffic share
Latest investments Show all
$29,000,000
Venture capital (Series A)
Libra Therapeutics
$11,200,000
Venture capital (Series A)
bodyport
Team Size
1–10
Employees
Location
Headquarters
Past year's investments
  • 4 rounds in the past year
  • $82.5M deployed in total
  • $20.6M avg per round
Latest rounds
  • Libra Therapeutics: Venture capital (Series A) ($29M)
  • bodyport: Venture capital (Series A) ($11.2M)
  • eTheRNA Immunotherapies: Venture capital (Series B) (€34M)